Your email has been successfully added to our mailing list.

×
0.0168354430379746 0.0253164556962026 0.0126582278481012 0.0632911392405063 0.0337552742616034 0.0253164556962026 -0.019789029535865 -0.00843881856540085
Stock impact report

Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I

Enzo Biochem, Inc (ENZ)  More Company Research Source: GlobeNewswire
Last enzo biochem, inc earnings: 12/7 04:10 pm Check Earnings Report
US:NYSE Investor Relations: enzo.com/corporate/investor-information
PDF Continues to Explore Opportunities for Use of the Compound as a Potential Treatment for COVID-19 NEW YORK, NY, June 23, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced it has received a patent for the treatment of liver cancer, U.S. Patent No. 10,675,255 entitled Sphingosine Pathway Modulating Compounds for the Treatment of Cancers. Enzo’s patent is directed to methods for treating hepatocellular carcinoma (HCC), the most common human liver cancer, using the company’s proprietary compound SK1-I and has a term extending into June 2038. Foreign patent applications in the same patent family are currently pending.   Elazar Rabbani, Ph.D., CEO of Enzo Biochem, Inc. commented: “This new application of our proprietary compound is an important step in our program to advance SK1-I as a potential treatment for liver cancer and other cancers. Both our internal studies and the work of others have shown that SK1-I [Read more]
Impact snapshot Event time: ENZ
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ENZ alerts
from News Quantified
Opt-in for
ENZ alerts

from News Quantified
Opt-in for
ENZ alerts

from News Quantified